Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited12.403615746428.4742
Domestic EquitiesDivi's Laboratories Limited8.82933117120.2689
Domestic EquitiesApollo Hospitals Enterprise Limited6.24851878414.3444
Domestic EquitiesMax Healthcare Institute Limited5.222212072111.9882
Domestic EquitiesTorrent Pharmaceuticals Limited4.82132644611.0679
Domestic EquitiesLupin Limited4.44464426210.2033
Domestic EquitiesAurobindo Pharma Limited4.36157205810.0125
Domestic EquitiesLaurus Labs Limited4.2438884899.7422
Domestic EquitiesFortis Healthcare Limited3.1147774717.1502
Domestic EquitiesCohance Lifesciences Limited3.07911462717.0685
Domestic EquitiesNeuland Laboratories Limited3.052046707.0064
Domestic EquitiesAlkem Laboratories Limited2.9293124536.7246
Domestic EquitiesGlenmark Pharmaceuticals Limited2.6911256736.1777
Domestic EquitiesAster DM Healthcare Limited2.2372732575.1357
Domestic EquitiesMankind Pharma Limited1.9113195294.3876
Domestic EquitiesSai Life Sciences Limited1.8446395954.2345
Domestic EquitiesDr. Reddy's Laboratories Limited1.8172315344.1716
Domestic EquitiesAbbott India Limited1.794916204.1205
Domestic EquitiesPark Medi World Limited1.66781660943.8286
Domestic EquitiesCipla Limited1.6425287923.7706
Domestic EquitiesIPCA Laboratories Limited1.4997224883.4427
Domestic EquitiesLinde India Limited1.369542953.1439
Domestic EquitiesShaily Engineering Plastics Limited1.2904116972.9624
Domestic EquitiesJubilant Ingrevia Limited1.2773410812.9322
Domestic EquitiesSBI Life Insurance Company Limited1.2619159262.8969
Domestic EquitiesFDC Limited1.2094761792.7763
Domestic EquitiesPiramal Pharma Limited1.19981701522.7543
Domestic EquitiesBiocon Limited1.1861757062.7228
Domestic EquitiesHealthcare Global Enterprises Limited1.0889436612.4998
Domestic EquitiesRainbow Childrens Medicare Limited0.9902181522.2732
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited0.937692132.1525
Domestic EquitiesStandard Engineering Technology Ltd0.90571485782.0791
Domestic EquitiesShilpa Medicare Limited0.8781495682.0157
Domestic EquitiesPoly Medicure Limited0.7933120441.8212
Domestic EquitiesCaplin Point Laboratories Limited0.7779104491.7857
Domestic EquitiesSupriya Lifescience Limited0.7680253701.7630
Domestic EquitiesZydus Lifesciences Limited0.6524167921.4977
Domestic EquitiesSyngene International Limited0.4546223151.0436
Total 96.8970 222.4411
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)3.1030 7.1233
Total 3.1030 7.1233
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.